Q1 2023 Holdings
Filed 2023-05-15 | 62 holdings | $1.4B | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2023-11-08) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr S&P 500 ETF TR TR(SPY)PutA | TR UNIT | 78462F103 | $167.8M | 410,000 | 11.7% |
| Natera Inc(NTRA) | COM | 632307104 | $156.6M | 2,819,770 | 10.9% |
| Invesco QQQ TR(QQQ)PutA | UNIT SER 1 | 46090E103 | $144.4M | 450,000 | 10.1% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $133.9M | 3,731,499 | 9.3% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $89.4M | 819,124 | 6.2% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $54.8M | 6,194,572 | 3.8% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $49.7M | 222,107 | 3.5% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $46.7M | 2,209,057 | 3.3% |
| Community Health SYS Inc New(CYH) | COM | 203668108 | $44.5M | 9,082,305 | 3.1% |
| Biogen Inc(BIIB) | COM | 09062X103 | $42.8M | 153,774 | 3.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $39.7M | 170,537 | 2.8% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $37.7M | 4,520,724 | 2.6% |
| Catalent Inc(CTLTEUR) | COM | 148806102 | $37.7M | 573,609 | 2.6% |
| Danaher Corporation(DHR) | COM | 235851102 | $37.5M | 148,685 | 2.6% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $24.8M | 689,676 | 1.7% |
| Spdr S&P 500 ETF TR | PUT | 78462F953 | $22.0M | 4,100 | 1.9% |
| Amarin Corp PLC | SPONS ADR NEW | 023111906 | $21.9M | 14,612,757 | 1.5% |
| Centene Corp del(CNC) | COM | 15135B101 | $18.2M | 288,426 | 1.3% |
| Amedisys Inc | COM | 023436908 | $16.5M | 224,263 | 1.2% |
| Icon PLC(ICLR) | SHS | G4705A100 | $16.4M | 76,788 | 1.1% |
| Avantor Inc(AVTR) | COM | 05352A100 | $15.2M | 717,614 | 1.1% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $14.4M | 2,536,665 | 1.0% |
| Bio-Techne Corp(TECH) | COM | 09073M104 | $14.0M | 188,659 | 1.0% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $13.9M | 1,788,529 | 1.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $11.8M | 218,726 | 0.8% |
| Ehealth Inc(EHTH) | COM | 28238P109 | $11.6M | 1,234,283 | 0.8% |
| Guardant Health Inc(GH) | COM | 40131M109 | $11.3M | 483,098 | 0.8% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $11.2M | 299,050 | 0.8% |
| Humana Inc(HUM) | COM | 444859102 | $11.1M | 22,762 | 0.8% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $10.8M | 303,369 | 0.8% |
| Invesco QQQ TR | PUT | 46090E953 | $10.4M | 4,500 | 0.9% |
| Shockwave MED Inc(SWAVUSD) | COM | 82489T104 | $10.3M | 47,577 | 0.7% |
| Elevance Health Inc | COM | 036752903 | $9.5M | 20,615 | 0.7% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $8.4M | 141,892 | 0.6% |
| Model N Inc(MODNEUR) | COM | 607525102 | $8.1M | 241,870 | 0.6% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $7.4M | 27,909 | 0.5% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $7.3M | 203,272 | 0.5% |
| Amneal Pharmaceuticals Inc(AMRX) | COM STK CL A | 03168L105 | $7.2M | 5,183,046 | 0.5% |
| Spdr SER TR(XBI)PutA | S&P BIOTECH | 78464A870 | $6.1M | 80,000 | 0.4% |
| Pennant Group Inc(PNTG) | COM | 70805E109 | $6.0M | 421,974 | 0.4% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $6.0M | 1,938,088 | 0.4% |
| Taro Pharmaceutical Inds LTD | SHS | M8737E108 | $6.0M | 245,267 | 0.4% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $5.7M | 171,999 | 0.4% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $5.0M | 724,406 | 0.3% |
| AMN Healthcare Svcs Inc(AMN)PutA | COM | 001744101 | $3.3M | 40,000 | 0.2% |
| Iqvia Hldgs Inc(IQV) | COM | 46266C105 | $2.9M | 14,416 | 0.2% |
| Heska Corp(HSKAEUR) | COM RESTRC NEW | 42805E306 | $2.6M | 26,409 | 0.2% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $2.5M | 185,595 | 0.2% |
| Merus N V | COM | N5749R100 | $2.4M | 129,056 | 0.2% |
| Medpace Hldgs Inc(MEDP) | COM | 58506Q109 | $2.2M | 11,668 | 0.2% |